Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability
H.S. sophomore Avg
New words:
attached , bar , dropping , fraud , fraudulent , preempted , slight , statute , suspicion , unsuccessful , voluntary
Removed:
acceptance ,
Administration ,
Agency ,
ancillary ,
April ,
AXL ,
biologic ,
biological ,
biomarker ,
bispecific ,
bundled ,
cabozantinib ,
capturing ,
care ,
CDE ,
Center ,
cGMP ,
chance ,
clearance ,
Committee , connective , construct , credited , CTGF , customary , decoy , delayed , demonstrated , denied , dependence , designated , designation , disbursed , discovery , disease , documentation , dose , dosed , EMA , enter , exclusivity , expansion , factor , Fast , favorable , fluctuated , Food , goal , government , halted , halting , healthy , immune , implicated , Importantly , IND , initiated , initiating , initiation , Institute , international , Investigational , Junior , kinase , larger , launch , Leader , Leland , line , long , mainland , matched , matching , measuring , mechanism , medical , Medicinal , neutralizing , NMPA , objective , offset , orphan , participate , pathway , perform , pharmacodynamic , pharmacokinetic , pharmacologically , platinum , PMDA , preclinically , preliminary , produce , profile , programming , promoting , proof , proprietary , protecting , protein , randomized , reaching , receptor , recognizing , recommendation , recurrent , referenced , registrational , reimbursement , repay , resistance , resistant , responding , role , run , screen , securing , serum , signal , signaling , significance , sublicense , sublicensing , substitute , suppression , survive , symposium , tangible , targeting , technical , technology , temporarily , therapeutic , therapy , tissue , track , typically , tyrosine , updated , utilize , work , WuXi , yearly
